Healthy growth with a CAGR of around 6% is forecast for the packaging market in the latest packaging report – The Global Pharmaceutical Packaging Market 2016–2020 – from Research and Markets.1 Packaging is becoming ever more complex as it is expected to do more, i.e. to engage with the consumer, to improve compliance and warn against tampering. Pharmaceutical manufacturers and contract packers, meanwhile, are faced with many challenges not only from non-compliance warning letters and recalls but also from continual package component changes (resin and film changes). It is increasingly important to stay on top of packaging guidance and regulations, particularly directives such as those for serialisation and track and trace technology, which require time and investment. Companies also face longer and more rigorous package validation testing requirements.
Among the key trends identified by the organiser of Pharmapack Europe (taking place in Paris on 10–11 February 2016) are the ongoing implementation of track and trace technologies and the impending European falsified medicines directive. Similarly, the European standard EN 16679, has recently come into effect and provides guidance for the application of tamper verification features to the packaging of medicinal products. By 2018, all prescription medicine will be required to include a tamper verification feature.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.Featured companies
- Companies:
- Aptar Beauty
- Körber Pharma Packaging AG